Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Healthcare

AstraZeneca Scores Twin Drug Approvals Alongside Vaccine Progress

AstraZeneca's manufacturing partner Oxford Biomedica said it had hired French pharma veteran Roch Doliveux as non-executive chairman as the gene and cell therapy company vies for major role in the vaccine.

Read More

Gilead Trades That Made Millions On COVID-19 Drug News Raise Eyebrows

Gilead's shares jumped nearly 10% following a media report detailing encouraging partial data from trials of the U.S. company's experimental drug remdesivir in severe COVID-19 patients.

Read More

Max India Sets Record Date As June 15 After NCLT Approves Demerger

The merged entity will continue to use the current brand name Max Healthcare with appropriate adjustments to its logo.

Read More

Sanofi Stops Enrolling COVID-19 Patients In Hydroxychloroquine Trials Amid Safety Concerns

The moves come after the World Health Organization paused its large trial of hydroxychloroquine after the British journal The Lancet reported patients getting the drug had increased death rates and irregular heartbeats.

Read More

Sun Pharma To Conduct Clinical Trial Of Pancreatitis Drug In COVID-19 Patients

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Read More

Moderna Extends Lipids Deal To Boost COVID-19 Vaccine Output

The expanded agreement with pharmaceutical ingredient supplier CordenPharma will be effective immediately to help meet its increasing demand over the coming months

Read More

GSK Aims For 1 Billion Doses With COVID Vaccine Booster Plan

GSK is working on its own COVID vaccine with French drugmaker Sanofi, one of the many projects to counter the respiratory illness that currently that has no treatment and has killed about 350,000 people.

Read More

Patanjali's Rs 250 Crore Debentures Issue Subscribed Within Three Minutes Of Opening

Patanjali Ayurved acquired the bankrupt Ruchi Soya for Rs 4,350 crore, maker of soya food brand Nutrela, through an insolvency process.

Read More

Drugmaker Sanofi To Raise Over $11 Billion Via Sale Of Regeneron Shares

Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.

Read More

Rising Swiss Rivalry As Roche And Novartis Target Same Diseases

Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.

Read More

Lilly, Junshi Biosciences Plan To Start Human Trials Of COVID-19 Antibody In Q2

Lilly and several other drugmakers such as Gilead Sciences, Pfizer Inc and Merck & Co Inc are racing to develop treatments or vaccines for the fast-spreading respiratory illness caused by the novel coronavirus.

Read More

India's Glenmark To Study Potential COVID-19 Drug Combination

Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for COVID-19.

Read More

Highest Spike of 6,977 COVID-19 Cases; India Now Among Top 10 Countries As Tally Reaches 1,38,845

India is now among the top 10 countries in the world regarding the total number of COVID-19 cases.

Read More

The Jab The World Awaits

The race to create a vaccine is on – the country that gets there first stands to gain in more ways than one By Jyotsna Sharma

Read More

Human Trials Of British Coronavirus Vaccine To Reach 10,000

Institutions across Britain had begun enrolling up to 10,260 adults and children to see how well the human immune system responds to the vaccine and how safe it is

Read More